| Literature DB >> 36137999 |
Yixin Wu1,2,3, Mingzheng Wu4, Abraham Vázquez-Guardado2,3, Joohee Kim2,3,5, Xin Zhang4, Raudel Avila6, Jin-Tae Kim2,3, Yujun Deng6,7, Yongjoon Yu8, Sarah Melzer9, Yun Bai1,2,3, Hyoseo Yoon4, Lingzi Meng1,2,3, Yi Zhang10,11, Hexia Guo1,2,3, Liu Hong12, Evangelos E Kanatzidis2,3,13, Chad R Haney14, Emily A Waters14, Anthony R Banks2,8, Ziying Hu2,3, Ferrona Lie8, Leonardo P Chamorro12, Bernardo L Sabatini9, Yonggang Huang15,16,17, Yevgenia Kozorovitskiy18,19, John A Rogers20,21,22,23,24,25,26,27,28,29.
Abstract
In vivo optogenetics and photopharmacology are two techniques for controlling neuronal activity that have immense potential in neuroscience research. Their applications in tether-free groups of animals have been limited in part due to tools availability. Here, we present a wireless, battery-free, programable multilateral optofluidic platform with user-selected modalities for optogenetics, pharmacology and photopharmacology. This system features mechanically compliant microfluidic and electronic interconnects, capabilities for dynamic control over the rates of drug delivery and real-time programmability, simultaneously for up to 256 separate devices in a single cage environment. Our behavioral experiments demonstrate control of motor behaviors in grouped mice through in vivo optogenetics with co-located gene delivery and controlled photolysis of caged glutamate. These optofluidic systems may expand the scope of wireless techniques to study neural processing in animal models.Entities:
Year: 2022 PMID: 36137999 DOI: 10.1038/s41467-022-32947-0
Source DB: PubMed Journal: Nat Commun ISSN: 2041-1723 Impact factor: 17.694